The use of fibrinolytic agents. Present status in the treatment of cardiovascular disease.
Fibrinolysins are involved in the dissolution of clots. They are still in the experimental stage and are not yet ready for use by practicing physicians. The materials available for clinical use have undesirable serious side effects. However, the future for fibrinolysins in clinical practice has promise.
D002318:Cardiovascular Diseases; D005341:Fibrinolysin; D005343:Fibrinolytic Agents; D006801:Humans; D006819:Hyaline Membrane Disease; D007231:Infant, Newborn
D005343:Fibrinolytic Agents; D005341:Fibrinolysin
CARDIOVASCULAR DISEASES; FIBRINOLYSIN; HYALINE MEMBRANE DISEASE